Orthopediatrics (KIDS) Equity Average (2017 - 2026)

Orthopediatrics' Equity Average history runs 10 years deep, the most recent figure standing at $342.7 million for Q1 2026.

• In Q1 2026, Equity Average fell 2.34% year-over-year to $342.7 million; the TTM figure through Mar 2026 stood at $342.7 million (down 2.34% YoY), while the FY2025 annual figure was $350.6 million, down 4.16% from the prior year.
• Equity Average was $342.7 million for Q1 2026 at Orthopediatrics, down from $348.0 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $381.0 million in Q4 2022 to a low of $220.2 million in Q1 2022.
• Historically, Equity Average has averaged $344.5 million across 5 years, with a median of $362.7 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Equity Average jumped 70.7% in 2023, then slipped 6.14% in 2025.
• A 5-year view of Equity Average shows it stood at $381.0 million in 2022, then decreased by 1.39% to $375.7 million in 2023, then retreated by 3.44% to $362.7 million in 2024, then retreated by 4.08% to $348.0 million in 2025, then slipped by 1.52% to $342.7 million in 2026.
• The last three Equity Average figures came in at $342.7 million (Q1 2026), $348.0 million (Q4 2025), and $352.4 million (Q3 2025), per Business Quant data.